Substance abuse may be a risk factor for earlier onset of Huntington disease

Journal of Neurology

Volumn 259, Issue 9, 2012, Pages 1824-1831

  Byars, Joanne A ^a,b   Beglinger, Leigh J ^a   Moser, David J ^a   Gonzalez Alegre, Pedro ^a   Nopoulos, Peg ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Alcohol abuse; Drug abuse; Hereditary neurodegenerative diseases; Huntington disease; Neurodegeneration; Substance abuse

Indexed keywords

ADULT; ALCOHOL ABUSE; ARTICLE; CAG REPEAT; CONTROLLED STUDY; DRUG ABUSE; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

AGE FACTORS; AGE OF ONSET; ANALYSIS OF VARIANCE; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 84867335398     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6415-8     Document Type: Article

References (35)

1. Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E et al (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci USA 101:3498-3503
2. Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 61:504-513
3. Reitz C, den Heijer T, van Duijn C, Hofman A, Breteler MM (2007) Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study. Neurology 69:998-1005
4. Harwood DG, Kalechstein A, Barker WW, Strauman S, St George-Hyslop P, Iglesias C et al (2009) The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease. Int J Geriatr Psychiatry 25:511-518
5. Sabia S, Marmot M, Dufouil C, Singh-Manoux A (2008) Smoking history and cognitive function in middle age from the Whitehall II study. Arch Intern Med 168:1165-1173
6. Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F et al (2010) Smoking duration, intensity, and risk of Parkinson disease. Neurology 74:878-884
7. Thomas VS, Rockwood KJ (2001) Alcohol abuse, cognitive impairment, and mortality among older people. J Am Geriatr Soc 49:415-420
8. Robbins TW, Ersche KD, Everitt BJ (2008) Drug addiction and the memory systems of the brain. Ann NY Acad Sci 1141:1-21
9. Buruma OJ, Van der Kamp W, Barendswaard EC, Roos RA, Kromhout D, Van der Velde EA (1987) Which factors influence age at onset and rate of progression in Huntington's disease? J Neurol Sci 80:299-306
10. Myers RH, Sax DS, Koroshetz WJ, Mastromauro C, Cupples LA, Kiely DK et al (1991) Factors associated with slow progression in Huntington's disease. Arch Neurol 48:800-804
11. Ehret JC, Day PS, Wiegand R, Wojcieszek J, Chambers RA (2007) Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families. Drug Alcohol Depend 86:283-286
12. Friedman JH, Trieschmann ME, Myers RH, Fernandez HH (2005) Monozygotic twins discordant for Huntington disease after 7 years. Arch Neurol 62:995-997
13. Palmer RH, Young SE, Hopfer CJ, Corley RP, Stallings MC, Crowley TJ et al (2009) Developmental epidemiology of drug use and abuse in adolescence and young adulthood: evidence of generalized risk. Drug Alcohol Depend 102:78-87
14. Zilberman M, Tavares H (2003) el-Guebaly N. Gender similarities and differences: the prevalence and course of alcohol-and other substance-related disorders. J Addict Dis 22:61-74
15. Hernandez-Avila CA, Rounsaville BJ, Kranzler HR (2004) Opioid-, cannabis-and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 74:265-272
16. Becker JB, Hu M (2008) Sex differences in drug abuse. Front Neuroendocrinol 29:36-47
17. Hommer D, Momenan R, Kaiser E, Rawlings R (2001) Evidence for a gender-related effect of alcoholism on brain volumes. Am J Psychiatry 158:198-204
18. Mann K, Ackermann K, Croissant B, Mundle G, Nakovics H, Diehl A (2005) Neuroimaging of gender differences in alcohol dependence: are women more vulnerable? Alcohol Clin Exp Res 29:896-901
19. Paul CA, Au R, Fredman L, Massaro JM, Seshadri S, Decarli C et al (2008) Association of alcohol consumption with brain volume in the Framingham study. Arch Neurol 65:1363-1367
20. Mucha L, Stephenson J, Morandi N, Dirani R (2006) Metaanalysis of disease risk associated with smoking, by gender and intensity of smoking. Gend Med 3:279-291
21. van der Plas EA, Crone EA, van den Wildenberg WP, Tranel D, Bechara A (2009) Executive control deficits in substancedependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women. J Clin Exp Neuropsychol 31:706-719
22. Pekmezovic T, Svetel M, Maric J, Dujmovic-Basuroski I, Dragasevic N, Keckarevic M et al (2007) Survival of Huntington's disease patients in Serbia: longer survival in female patients. Eur J Epidemiol 22:523-526
23. Foroud T, Gray J, Ivashina J, Conneally PM (1999) Differences in duration of Huntington's disease based on age at onset. J Neurol Neurosurg Psychiatry 66:52-56
24. Bode FJ, Stephan M, Suhling H, Pabst R, Straub RH, Raber KA et al (2008) Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32 ? neurons in males. Hum Mol Genet 17:2595-2609
25. Dorner JL, Miller BR, Barton SJ, Brock TJ, Rebec GV (2007) Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease. Behav Brain Res 178:90-97
26. Hasin DS, Stinson FS, Ogburn E, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64:830-842
27. Compton WM, Thomas YF, Stinson FS, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64:566-576
28. Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol 81:294-330
29. Davis MI (2008) Ethanol-BDNF interactions: still more questions than answers. Pharmacol Ther 118:36-57
30. Yeom M, Shim I, Lee HJ, Hahm DH (2005) Proteomic analysis of nicotine-associated protein expression in the striatum of repeated nicotine-treated rats. Biochem Biophys Res Commun 326:321-328
31. Kenny PJ, File SE, Rattray M (2000) Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res 85:234-238
32. Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56(Suppl 1):73-82
33. Bezprozvanny I (2009) Calcium signaling and neurodegenerative diseases. Trends Mol Med 15:89-100
34. Lee AM, Messing RO (2008) Protein kinases and addiction. Ann NY Acad Sci 1141:22-57
35. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA (2004) Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61:1107-1115